Detroit, Michigan – December 13, 2010 – Ash Stevens, Inc. (ASI) announced today that Dr. Stephen A. Munk, President & CEO, joined the Board of Governors of the Society of Chemical Manufacturers and Affiliates (SOCMA), the leading US-based trade association representing the batch, custom and specialty chemical industry. SOCMA supports chemical manufacturers with commercial and networking opportunities, advocates for the passage of rational laws and regulation, and works to increase public confidence in the industry.
Dr. Munk was elected to the Board during SOCMA's 89th Annual Membership Meeting in New York on December 6, 2010.
"As a longtime SOCMA member, I look forward to assisting the Board in ensuring that the mission, policies and strategic direction of the association are aligned with membership needs," said Dr. Munk.
"We are pleased to welcome Dr. Munk as the newest member of SOCMA's Board of Governors and appreciate the expertise and energy he will bring to this role," said Dr. Larry Brotherton, Chairman of the Board and President and CEO of Ortec, Inc. "I am confident that Dr. Munk will help us successfully lead this organization into the future."
SOCMA's Board of Governors provides strategic direction, maintains fiscal responsibility, and helps management develop business plans to deliver member value. Through regular meetings, the Board ensures effective organizational planning and sees that association resources are managed responsibly.
About Ash Stevens, Inc.
Ash Stevens, Inc. (ASI) is a full service Contract Pharmaceutical Manufacturer offering comprehensive small-molecule drug substance development and cGMP manufacturing services. Founded in 1962 and headquartered in Detroit, Michigan, ASI has extensive experience developing and manufacturing Active Pharmaceutical Ingredients (APIs) for commercial clients in the Life Sciences industry developing innovator small-molecule therapeutics. ASI is a longtime provider of contract research services to the National Institutes of Health and the National Cancer Institute and has worked on many of the drugs developed through these government agencies. To date, ASI has received eleven FDA manufacturing approvals for innovator APIs, including Four Fast-Track manufacturing approvals for the active ingredients in the oncology drugs Velcade®, Vidaza®, and Clolar®. Services offered by Ash Stevens include: process development and scale-up; cGMP manufacturing; the development and cGMP manufacture of highly potent APIs using barrier-isolation technology; comprehensive analytical capabilities (including method development, stability studies and qualification of reference standards); and regulatory support for all phases of drug development and manufacturing. For more information, visit www.ashstevens.com.
SOCMA is the only U.S. based trade association dedicated solely to the batch, custom and specialty chemical industry. Since 1921, we have represented a diverse membership of small, medium and large chemical companies, making us the leading authority on this sector. SOCMA has a global membership of more than 200 companies. For more information on our services and products, please visit www.socma.com.
ChemStewards® is SOCMA's flagship environmental, health, safety and security (EHS&S) continuous performance improvement program. ChemStewards was created from industry's commitment to reducing our environmental footprint. Industry created ChemStewards to meet the unique needs of the batch, custom, and specialty chemical industry. As a mandatory requirement for SOCMA members engaged in the manufacturing or handling of chemicals, ChemStewards is helping participants reach for superior EHS&S performance. To learn more visit www.chemstewards.com.
# # #